ArticleFrontiers in medicine2026
Development and internal-external validation of a machine learning-based risk prediction model for multidrug resistance in mechanically ventilated ICU patients with chronic obstructive pulmonary disease.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to develop and conduct internal-external validation of a machine learning-based risk prediction model for multidrug-resistant (MDR) infection in mechanically ventilated intensive care unit (ICU) patients with chronic obstructive pulmonary disease (COPD), so as to provide evidence for early identification of high-risk individuals, optimization of antimicrobial strategies, and reduction of infection-related adverse outcomes. Methods: We retrospectively analyzed 477 mechanically ventilated COPD ICU patients from the MIMIC-IV database, which were divided into a training set (333 cases) and an internal validation set (144 cases) at a ratio of 7:3, with MDR infection as the endpoint. Feature selection was performed using the Boruta algorithm and least absolute shrinkage and selection operator (LASSO). Seven machine learning algorithms were adopted for model training and construction with 10-fold cross-validation. Model performance was evaluated by AUC, accuracy, sensitivity, specificity, F1 score, calibration curve and decision curve analysis. External validation was conducted using 371 independent single-center clinical cases. The optimal model was interpreted by Shapley additive explanations (SHAP) analysis, and a predictive nomogram was established. Results: Five core predictors were identified, including red blood cell count, hemoglobin, hematocrit, blood urea nitrogen and creatinine. The K-nearest neighbor (KNN) model outperformed other algorithms, with an internal validation AUC of 0.642 (95% CI: 0.518-0.766) and an external validation AUC of 0.639 (95% CI: 0.508-0.769), accompanied by favorable accuracy, calibration and clinical net benefit. SHAP analysis indicated that hematocrit was the primary predictive factor; elevated red blood cell-related indexes increased MDR risk, while elevated blood urea nitrogen and creatinine decreased the risk. Conclusion: MDR infection in mechanically ventilated COPD ICU patients is closely associated with five routine laboratory indicators. The established KNN model and nomogram show favorable predictive value and generalizability, which can achieve rapid individualized risk quantification and serve as an auxiliary tool for early risk stratification and rational antimicrobial selection. It should be emphasized that this model is only used for preliminary screening and cannot replace microbial culture and drug susceptibility testing as the gold standard for definitive diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.